News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Sabine D. Brookman-May: Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression
Photo from Sabine D. Brookman-May/X
Aug 21, 2024, 13:41

Sabine D. Brookman-May: Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression

Sabine D. Brookman-May, Professor of Urology at the Ludwig-Maximilians University of Munchen, posted on X:

“Words of Wisdom Re: Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression.
Shining example of the impact of consistently applied evidence-based interventions.”

Sabine D. Brookman-May

Re: Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non–muscle-invasive Bladder Cancer

Autors: Sabine D. Brookman-May, Ashish M. Kamat, Matthias May

Sabine D. Brookman-May

Source: Sabine D. Brookman-May/X

Ashish M. Kamat bladder cancer cancer Matthias May Nonmuscle Invasive Bladder Cancer (NMIBC) OncoDaily Oncology Sabine D. Brookman-May
Special Coverage
Blog
Nov 13, 2024, 11:30
ABC Global Alliance - Learning more about brain metastases in breast cancer
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network